Search
EN

About the deal

Capitalmind Investec (an Investec company) advised the shareholders of kempf und pfaltz on the sale of the company to Unilabs

The owners of kempf und pfaltz sold the majority of their shares to strategic investor Unilabs.

kempf und pfaltz is a  leading Swiss dermatopathology lab by market share and level of expertise operating a state-of-the-art laboratory in Zurich. Certified under ISO 9001:2015 standards, the company is also recognized as a Category D training centre by the Swiss Society of Pathology, a training centre for dermatopathology, and an accredited centre by the international Committee of Dermatopathology.

Unilabs is a leading international provider of diagnostic services offering a complete range of laboratory, pathology, genetics and imaging services to patients across four continents.

The partnership with kempf und pfaltz puts Unilabs at the forefront of dermatopathology by securing long-term, in-house, dermatopathology expertise, boosting reputation, and transforming Unilabs’ ability to serve customers and patients in the Zurich region.

The owners of kempf und pfaltz will continue to lead the Zurich lab as co-shareholders, ensuring continuity for its employees and referring doctors and contributing their extensive expertise in dermatopathology.

What we did

Capitalmind Investec has advised the owners of kempf und pfaltz throughout the entire M&A process, from the preparatory work, contacting and structuring, to the successful closure of the transaction.

“Working with Capitalmind Investec was an excellent experience. Thanks to their efficient project management, an ambitious timeline was met and a complex transaction structure could be successfully implemented. Their deep understanding of the medical market and strategic approach to the project ensured that in Unilabs we found the perfect partner with the same long-term and high quality-focused vision for our company. We are extremely satisfied with the result and can recommend Capitalmind Investec in every respect.“

Prof. Dr. Werner Kempf, co-founder of kempf und pfaltz

Sectors
Deal Type
Target Headquarter
Date
December 2024
Parties

Subscribe to our Insights

    Sector preference